Cargando…
Detection of loss of heterozygosity in patients with urinary bladder carcinoma: neoplastic tissue vs. urine sediment cells
INTRODUCTION: Loss of heterozygosity (LOH) is frequently observed in urinary bladder neoplasms. In the reported study, an attempt was undertaken to determine the loss of heterozygosity of TP53(17p13), RB1(13q14), CDKN2A/ ARF(9p21) genes in DNA from neoplastic tissue, collected from patients with dia...
Autores principales: | Traczyk, Magdalena, Borkowska, Edyta, Jędrzejczyk, Adam, Pietrusiński, Michał, Rożniecki, Marek, Marks, Piotr, Kałużewski, Bogdan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921734/ https://www.ncbi.nlm.nih.gov/pubmed/24578886 http://dx.doi.org/10.5173/ceju.2011.03.art16 |
Ejemplares similares
-
Significance of CDKN2A gene A148T variant in patients with bladder cancer
por: Borkowska, Edyta, et al.
Publicado: (2011) -
Polymorphic variants of H-RAS protooncogene and their possible role in bladder cancer etiology
por: Traczyk, Magdalena, et al.
Publicado: (2012) -
Artificial neural network in predicting bladder cancer recurrence
por: Borkowska, Edyta, et al.
Publicado: (2012) -
The prevalence of CHEK2 and CYP1B1 mutations/polymorphisms in urinary bladder cancer
por: Banaszkiewicz, Monika, et al.
Publicado: (2012) -
The A148T variant of CDKN2A gene in bladder cancer
por: Borkowska, E, et al.
Publicado: (2011)